There were 1,471 press releases posted in the last 24 hours and 435,506 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
VBI Vaccines Announces FDA Acceptance of Investigational New Drug Application for Sci-B-Vac(R) Phase 3 Clinical Program

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image